Keywords: strong, ph, ii, data, helix, topical, inf-alpha-2b

Strong Ph II data for Helix' topical INF-alpha-2b

Article | 16 April 2007

Print This

Canadian drugmaker Helix BioPharma has reported positive results from a Phase II study of its topical interferon alpha-2b in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in